Product Safety Team (PST) lead for late stage oncology products. Collaborate with development medical lead to set oncology program strategy. Own safety through the product lifecycle (surveillance, signal detection, validation/assessment, risk assessment/mitigations, tox management). Partner with PK/toxicology, regulatory, clinical development, and medical affairs to guide dose selection/regimen, inclusion/exclusion criteria, and safety monitoring for first-in-clinical trials and PMOS. Interpret pharmacovigilance regulations and lead safety components of pre-NDA and NDA/sNDA submissions, regulatory responses, label/label updates, and RMPs.
Responsibilities:
- Conduct safety surveillance using pharmacology/chemistry/non-clinical toxicology knowledge.
- Lead safety surveillance for pharmaceutical/biologic/drug-device combined products.
- Set strategy for key pharmacovigilance documents (medical safety assessments, regulatory responses, risk management plans, NDA/sNDA safety components).
- Apply regulatory guidance for safety surveillance and PV document authorship.
- Analyze/interpret aggregate safety data and communicate to cross-functional teams, leadership, and externally.
- Write/review/provide input on technical documents.
- Lead periodic report strategy (DSURs, PSURs, PADERs, etc.).
- Implement risk management strategies for assigned products.
- Engage/coaching/mentoring; support publications/initiatives.
- Adapt in fast-paced environment.
Qualifications:
- MD/DO with 2+ years internal medicine residency with patient management required; PhD or Clinical Pharmacology fellowship preferred.
- 2β5 years pharma Pharmacovigilance/Clinical Development.
- Prior regulatory submission support (IND/BLA) required.
- Oncology patient safety experience required.
- Ability to analyze clinical/epidemiological data; present recommendations; write/review technical documents; lead cross-functional teams.
Benefits (if eligible): Paid time off; medical/dental/vision insurance; 401(k); long-term incentive program eligibility.